Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.
Atsushi HashizumeMasahisa KatsunoKeisuke SuzukiHaruhiko BannoYu TakeuchiMotoshi KawashimaNoriaki SugaTomoo ManoAmane ArakiYasuhiro HijikataAkihiro HirakawaTakashi Tsuboinull nullPublished in: Journal of neurology (2019)
The efficacy of leuprorelin acetate for patients with SBMA was statistically similar in two randomized-controlled trials, and suggested that leuprorelin acetate may be effective and safe. Further investigations are needed to clarify the promising efficacy of the drug.